Dechra Pharmaceuticals Share Price (DPH)

1,159.50 +6.50 (+0.56%) delayed: 1:36PM BST
Bid price 1,159.00 Open price 1,157.00
Ask price 1,160.00 Prev close 1,153.00
High price 1,160.00 Spread 0.09%
Low price 1,149.00 Volume 15,702

Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.

Dechra Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Dechra Pharmaceuticals share price charts

Dechra Pharmaceuticals Share Price Information

Name Dechra Pharmaceuticals Epic DPH
Sector Pharmaceuticals & Biotechnology ISIN GB0009633180
Activites Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Index FTSE 250

Dechra Pharmaceuticals Key Numbers

Latest Share Price (p) 1,159.50 Net Gearing (%) 17.70
Market Capitalisation (£m) 1,042.94 Gross Gearing (%) 33.42
Shares in issue (m) 92.71 Debt Ratio 21.58
P/E Ratio 50.81 Debt-to-Equity Ratio 0.55
Total dividends per share (p) 16.94 Assets / Equity Ratio 1.50
Dividend Yield (%) 1.54 Price to book value 5.36
Dividend cover (x) 1.25 ROCE (%) 10.41
Earning per share (p) 22.14 EPS Growth (%) -67.23
52 week high / low 1,250.00 / 902.50 DPS Growth (%) 10.00

Dechra Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
18/03/2016 EXR Ian Page CEO 87,905
18/03/2016 SEXR Ian Page CEO 41,440
18/03/2016 EXR Tony Griffin ED 32,027
09/09/2015 EXR Anne-Françoise Nesmes FD 38,859
09/09/2015 SEXR Anne-Françoise Nesmes FD 18,319

More Dechra Pharmaceuticals Director Deals >>

Dechra Pharmaceuticals Company News

15:37 16/05/2016

Holding(s) in Company

/* */ RNS Number : 3839Y Dechra Pharmaceuticals PLC 16 May 2016   TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i   1. Identity of the issuer or the underlying issuer of existing shares to which voting...

10:55 29/04/2016

Total Voting Rights

/* */ RNS Number : 8300W Dechra Pharmaceuticals PLC 29 April 2016       29 April 2016   Dechra ® Pharmaceuticals PLC (Dechra or the Company)      In conformity with DTR 5.6.1R, the Company notifies the...

More Dechra Pharmaceuticals Company News >>

Register now for FREE Dechra Pharmaceuticals company news

Dechra Pharmaceuticals Share Price Discussions

more than 1 year ago

A really dreary share (DPH)

A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...

Register now for FREE Dechra Pharmaceuticals share price discussions